Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monitoring of MxA mRNA Expression as a Marker of Response to Interferon beta Therapy in Multiple Sclerosis
2011-001956-12Phase 4Completed
- Sponsor
- Motol University Hospital
- Start
- May 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of interferon beta-1a and interferon beta-1b in multiple sclerosis (MS), sponsored by Motol University Hospital. Primary endpoint: Clinical efficacy of interferon beta correlated with MxA mRNA expression. Started May 2011; status: completed.
02
Drugs
interferon beta-1ainterferon beta-1b
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2011-001956-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001956-12.